HSP90 inhibition overcomes EGFR amplification‐induced resistance to third‐generation EGFR‐TKIs

BACKGROUND: Patients with non‐small cell lung cancer (NSCLC) harboring activating EGFR mutations are sensitive to epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs) but inevitably develop resistance to the inhibitors mostly through acquisition of the secondary T790M mutation. Al...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Thorac Cancer
Main Authors: Watanabe, Sho, Goto, Yasushi, Yasuda, Hiroyuki, Kohno, Takashi, Motoi, Noriko, Ohe, Yuichiro, Nishikawa, Hiroyoshi, Kobayashi, Susumu S., Kuwano, Kazuyoshi, Togashi, Yosuke
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons Australia, Ltd 2021
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7919131/
https://ncbi.nlm.nih.gov/pubmed/33471376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13839
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker